Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 510 + MVASI in KRAS G12C NSCLC with Brain Metastasis
NCT05180422Phase 2Withdrawn
- Sponsor
- Criterium
- Start
- Jun 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sotorasib in non-small cell lung cancer (NSCLC), sponsored by Criterium. Planned start Jun 2022; status: withdrawn.
02
Drugs
sotorasib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05180422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05180422.